Navigation Links
tra in Medical Technology

Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study

...its primary endpoints of safety and tolerability. tra showed no increase in major and minor Thrombolysis...y are encouraging as they support the viability of tra as a potential new antiplatelet therapy option," s...and the development of blood clots. In the study, tra showed a much higher TRAP-induced platelet aggrega...

New Study Proves Multiple Births From IVF Can Be Avoided

...n cost is not a factor. (Logo: http://www.newscom.com/cgi-bin/prnh/20090203/DC66439LOGO ) The published study, " Elective single embryo tra n sfer: A 6-year progressive implementation of 784 single blastocyst transfers and the influence of payment method on patient choice ," which is ava...

Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders

...ituximab arm (2 percent in dexamethasone arm versus 6 percent in dexamethasone-plus-rituximab arm). Effects of Prophylactic Platelet Dose on tra n sfusion Outcomes (PLADO Trial) [Abstract #2 8 5] Sherrill J. Slichter, MD, Puget Sound B lood Center f or the National Hea...

SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients

... these results add to the evidence indicating that tra may be a promising therapeutic option for patients...y, we are continuing to evaluate the potential for tra as a novel agent in reducing the incidence of card...s randomized to one of three oral loading doses of tra (10 mg, 20 mg, 40 mg) plus standard of care (clopi...

Schering-Plough Announces Presentation of Phase II Trial Results for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual Meeting of The American College of Cardiology/i2 Summit

...RA-PCI) trial, has been accepted as a late-breaker presentation. The trial was designed to evaluate the safety and tolerability of Schering-Plough's tra coadminstered with standard of care antithrombotic therapy (including aspirin and clopidogrel) in patients undergoing percutaneous coronary interventi...

Media Advisory: ACC Updated Schedule

...l was designed to evaluate the safety and tolerability of Schering-Plough's tra coadminstered with standard of care antithrombotic therapy (including aspir...h at 60 days compared with patients treated with the standard of care. tra Late-Breaker Trial Data Presentation: Results of a Multinational Randomiz...

More>>

Other Tags
(Date:3/5/2015)... Angeles, CA (PRWEB) March 05, 2015 ... article titled “Butt Augmentation, Labiaplasty on the Rise, Plastic ... reported by the American Society for Aesthetic Plastic ... Surgeons . Both groups reported a year-over-year doubling of ... of the physicians quoted in the article, this increase ...
(Date:3/5/2015)... Battle Creek, Michigan (PRWEB) March 05, 2015 ... celebrates the opportunity to shatter myths about drug and ... Forever Recovery has released a Fact Sheet with information ... substance abuse. Launched in 2010 by the National Institute ... about drugs and alcohol aims to counteract the illusions ...
(Date:3/5/2015)... 05, 2015 At the 7th ... leaders in addiction treatment met today in Jackson, Mississippi ... clinical practices. Among the numerous respected speakers will be ... address the role that pain medications have had in ... treatment options. , "It is hard to believe that ...
(Date:3/5/2015)... March 05, 2015 Califia Farms ... announced at Natural Products Expo West that its popular ... 100 percent soy and dairy free. Califia Farms Vegan ... bottle and are packed with six grams of an ... includes fiber, B vitamins and magnesium. , Protein is ...
(Date:3/5/2015)... Ore. (PRWEB) March 05, 2015 ... sciences university founded in 1904, has launched a ... and positive lifestyle changes. The Northwest Center for ... health professionals, support community outreach, and conduct research ... functional medicine, diet and nutrition. The center will ...
Breaking Medicine News(10 mins):Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/12/2015)... 12, 2015   MedNet Solutions , a ... study management systems, has recently bolstered its ... iMedNet as the eClinical ... and healthcare consultants.  Building on the Program,s existing ... and numerous co-marketing opportunities), MedNet,s new and improved ...
(Date:2/9/2015)... Feb. 9, 2015  Lintec of America recently announced ... carbon nanotube (CNT) macrostructures, including sheets, yarns and ribbons, ... Leveraging the vast industrial resources of the ... , Lintec of America is forming the Nano-Science ... , focusing on scaling up the manufacturing and ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
Other Contents